Tscan Therapeutics Inc
(TCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -106,789 | -71,079 | -34,127 | -127,499 | -91,690 |
| Depreciation Amortization | 2,143 | 1,376 | 678 | 4,108 | 3,397 |
| Accounts payable and accrued liabilities | 2,056 | 123 | 558 | 1,994 | 1,011 |
| Other Working Capital | -6,357 | -5,998 | -6,384 | 5,054 | -205 |
| Other Operating Activity | 5,630 | 4,725 | 1,689 | 5,521 | 4,077 |
| Operating Cash Flow | $-103,317 | $-70,853 | $-37,586 | $-110,822 | $-83,410 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,236 | -2,811 | -1,532 | -3,825 | -2,937 |
| Purchase Of Investment | -87,471 | -87,472 | -60,938 | -241,445 | -194,116 |
| Sale Of Investment | 186,250 | 152,250 | 76,000 | 192,657 | 117,147 |
| Investing Cash Flow | $94,543 | $61,967 | $13,530 | $-52,613 | $-79,906 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 32,457 | N/A |
| Debt Repayment | N/A | N/A | N/A | -17,144 | N/A |
| Common Stock Issued | N/A | 191 | N/A | 193,452 | 163,075 |
| Other Financing Activity | -409 | -600 | -525 | 0 | 0 |
| Financing Cash Flow | $-409 | $-409 | $-525 | $208,765 | $163,075 |
| Beginning Cash Position | 183,720 | 183,720 | 183,720 | 138,390 | 138,390 |
| End Cash Position | 174,537 | 174,425 | 159,139 | 183,720 | 138,149 |
| Net Cash Flow | $-9,183 | $-9,295 | $-24,581 | $45,330 | $-241 |
| Free Cash Flow | |||||
| Operating Cash Flow | -103,317 | -70,853 | -37,586 | -110,822 | -83,410 |
| Capital Expenditure | -4,236 | -2,811 | -1,532 | -3,825 | -2,937 |
| Free Cash Flow | -107,553 | -73,664 | -39,118 | -114,647 | -86,347 |